Trial Profile
A proof of concept study on the effect of tianeptine on opioidinduced respiratory depression
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Aug 2021
Price :
$35
*
At a glance
- Drugs Tianeptine (Primary)
- Indications Respiratory insufficiency
- Focus Proof of concept; Therapeutic Use
- Acronyms STORD
- 10 Jan 2015 Planned number of patients changed from 16 to 32 as reported by Netherlands Trial Register.
- 18 Apr 2014 New trial record